Flexapet
Flexapet is a formulation designed to provide comprehensive support for joint health in dogs. Its composition combines structural cartilage components with compounds that help modulate the inflammatory response associated with degenerative joint processes. This approach supports the nutritional management of chronic joint conditions and can also be used preventively in animals at higher risk of developing joint disease, helping maintain mobility and patient comfort.
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
DIFFERENTIATORS
BENEFITS AND COMPETITIVE ADVANTAGES
Joint immunomodulator.
Flavoured tablets.
Joint immunomodulator.
Wide dosing range.
TECHNICAL DETAILS
Information
COMPOSITION
– Vitamin E acetate 10 mg.
– Magnesium sulfate 10 mg.
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Dogs of all ages: Under 20 kg: 1/2 tablet per day, given once daily. 20 kg or more: 1 tablet per day, given once daily.
Cats of all ages: 1/4 tablet per day.
As a general recommendation, a minimum of 60 days of use is suggested, especially during cold and humid periods. After 90 days, a marked reduction in pain and an increase in mobility and joint range of motion are observed. It can be used for extended periods without issue. Continuous supplementation is recommended for obese animals or those performing intense work or exercise.
Animals with osteoarthritis should remain on long-term supplementation. Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
- Joint Health
- Opioid Pain Management
- NSAID Pain Management
- Neuropathic Pain
- Steroidal Anti-inflammatory Drugs
- Antibiotics
- Gastrointestinal Health
- Hepatic Health
- Integrative Functional Supplementation
- Vitamins and Minerals
- Omega
- Laxatives
- Anticholinergic – Antispasmodics
- Hemostatic Agents
- Internal Antiparasitics
- External Antiparasitics
- Hemostatic Agent
Flexapet
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
Flexapet is a formulation designed to provide comprehensive support for joint health in dogs. Its composition combines structural cartilage components with compounds that help modulate the inflammatory response associated with degenerative joint processes. This approach supports the nutritional management of chronic joint conditions and can also be used preventively in animals at higher risk of developing joint disease, helping maintain mobility and patient comfort.
Joint immunomodulator.
Flavoured tablets.
Joint immunomodulator.
Wide dosing range.
TECHNICAL DETAILS
Information
COMPOSITION
– Vitamin E acetate 10 mg.
– Magnesium sulfate 10 mg.
– Excipients q.s. for 1 tablet.
DOSAGE AND ADMINISTRATION
Dogs of all ages: Under 20 kg: 1/2 tablet per day, given once daily. 20 kg or more: 1 tablet per day, given once daily.
Cats of all ages: 1/4 tablet per day.
As a general recommendation, a minimum of 60 days of use is suggested, especially during cold and humid periods. After 90 days, a marked reduction in pain and an increase in mobility and joint range of motion are observed. It can be used for extended periods without issue. Continuous supplementation is recommended for obese animals or those performing intense work or exercise.
Animals with osteoarthritis should remain on long-term supplementation. Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.